Friday, October 10, 2025 - Agenda

More details coming soon

Rami Heart, DO, FACOI,

Tiffany Di Pietro, DO, FACOI (she/her/hers), Founder/CEO

Doxycycline ("DoxyPEP") has been approved by the CDC for post-exposure prophylaxis for certain populations. In Florida, the doxyPEP guidelines that I developed are inclusive of all populations. Since approval, doxyPEP has generated a lot of conversation and debate, including questionable future antibiotic resistance, changes in gut microbiome, side effect profile, use in women, and more. These will all be explored and discussed during my presentation.

Learning Objectives:

• Upon completion, participants will be able to define doxyPEP and identify the populations for which it is approved for.
• Upon completion, participants will be able to identify and address concerns related to doxyPEP usage.
• Upon completion, participants will be able to form their own scientific opinions regarding doxyPEP based on information learned in today's presentation.

Andrea Sciberras, Statewide Medical Director, DO, AAHIVS, FACOI, FACP, Internal Medicine, HIV Specialist

Learning Objectives:

• Describe how perception, belief, and mindset influence one’s ability to achieve personal and professional goals.
• Demonstrate the ability to apply alternative ways of thinking by engaging in a guided mental exercise designed to challenge traditional problem-solving approaches.
• Assess critically how opening the mind to new perspectives can impact decision-making, creativity, and self-efficacy in both personal and professional contexts.

Craig Karges, CSP, CPAE (he/him/his), Award-winning Entertainer, Nationally Recognized Speaker & Author, Karges Productions

More details coming soon

Stephen J. Ruffenach, DO, MS, FACOI, Adjunct Clinical Assistant Professor of Preclinical Medicine, Burrell College of Osteopathic Medicine

Learning Objectives:

• Analyze current trends in colorectal cancer incidence and mortality, with emphasis on younger populations and disparities.
• Evaluate updated colorectal cancer screening guidelines, including starting age, modalities, and risk-based modifications.
• Compare the benefits, limitations, and recommended intervals of available screening methods to optimize patient care.

Joseph Salhab, DO (he/him/his), Board Certified Gastroenterologist, AdventHealth Altamonate

Learning Objectives:

• Increase the use of guideline-recommended care for chronic Kidney Disease (CKD).
• Summarize the appropriate use of new drugs approved for managing CKD.
• Reduce the use of common drugs that may be nephrotoxic in patients with or at risk for CKD.

Tarra I. Faulk, DO, FASN, CPE (she/her/hers), Staff Nephrologist, Joint Base San Antonio - Fort Sam Houston, TX / United States Air Force

Mark D. Baldwin, DO, MACOI, FASN (he/him/his), Professor and Chair, Department of Primary Care Medicine, Arkansas Colleges of Health Education, College of Osteopathic Medicine

Learning Objectives:

• Discuss the diagnosis, screening, and lifestyle recommendations in obesity.
• Describe diabetes treatment algorithms and updated goals, particularly in the obese diabetic population.
• Demonstrate medical management of obesity in patients with and without diabetes.

Brian Lake, DO (he/him/his), Endocrinologist, Lake Endocrinology and Diabetes, PLLC

Learning Objectives:

• Upon completion, participant will be able to compose a more efficient evaluation and management patient note.
• Upon completion, participant will be able to articulate a concise note that is compliant for current CPT rules.
• Upon completion, participant will be able to identify area of their current documentation that are inefficient, outdated and time consuming.

Jill M. Young, CEMC, CPC, CEDC, CIMC (she/her/hers), Principal Consultant, Young Medical Consulting, LLC

Learning Objectives:

• Understand appropriate testing to determine if adrenal lesion is hypersecretory.
• Interpret features of cross sectional imaging.
• Determine when a biopsy of an adrenal lesion may be warranted.

Louis Haenel,IV, DO, FACOI (he/him/his), Endocrinologist, Roper St Francis

Brian Lake, DO (he/him/his), Endocrinologist, Lake Endocrinology and Diabetes, PLLC

Learning Objectives:

• Understand the importance of iron deficiency anemia (IDA).
• Review GI-related causes and evaluation strategies.
• Learn updated management approaches (oral vs IV iron).

Emmanual A. McDonald, DO (he/him/his), Gastroenterologist, Advent Health

Learning Objectives:

• Understand the fundamental role of endothelial cells in vascular health.
• Define endothelial cell dysfunction (ECD) and its key molecular mechanisms.
• Appreciate the clinical implications of ECD for patient management.

Stephen J. Ruffenach, DO, MS, FACOI, Adjunct Clinical Assistant Professor of Preclinical Medicine, Burrell College of Osteopathic Medicine

Mark D. Baldwin, DO, MACOI, FASN (he/him/his), Professor and Chair, Department of Primary Care Medicine, Arkansas Colleges of Health Education, College of Osteopathic Medicine

Learning Objectives:

• Explain the pathophysiology and clinical manifestations of hyperthyroidism.
• Review the diagnostic approach of hyperthyroidism.
• Discuss the complications of untreated hyperthyroidism.

Ania Janicka, DO, Practice Partner and Core Attending Endocrine Fellowship, Diabetes Care Center

Brian Lake, DO (he/him/his), Endocrinologist, Lake Endocrinology and Diabetes, PLLC

Learning Objectives:

• Increased awareness of the epidemiology and clinical manifestations of MASLD.
• Understand how to diagnose and stage liver disease severity in patients with MASLD.
• Know what the current recommendations and treatments are for patients with MASLD.

Robert J. Fontana, MD, Professor of Medicine, University of Michigan

Learning Objectives:

• Review the new AHA 2025 Hypertension Guidelines.
• Discuss the recommendations for morning vs bedtime dosage of antihypertensive medication.
• Describe to impact of lower diastolic blood pressures on cardiovascular outcomes and all cause mortality.
• Review the recent comparison of spironolactone to amiloride in the treatment of resistant hypertension.

Mark D. Baldwin, DO, MACOI, FASN (he/him/his), Professor and Chair, Department of Primary Care Medicine, Arkansas Colleges of Health Education, College of Osteopathic Medicine

Learning Objectives:

• Learn how to be physician climate innovators, educators, collaborators, and catalysts for change.
• Understand climate impacts on human health and which patients are vulnerable and why.
• Learn how to help patients by using osteopathic principles and the climate “lens” & a “one health” approach.

Mary Schaefer Badger, DO, FACOI, FAWM, Internal Medicine, Retired

Learning Objectives:

• Compare residency programs and access insights from DOs.
• Select mentorship opportunities that are the best fit for your expertise, interests, and availability.
• Explore career resources and tools to help with the next step of your career journey.

Carrie Simon, CAPM, Manager, Emerging DO Platform, AOIA

More details coming soon

David H. Lindner, DO, MBA, FCCP, FACOI (he/him/his), Section Chair, Pulmonary & Critical Care, NCH Health Care

Learning Objectives:

• Summarize what comprises critical care.
• Contrast what is and is not included in critical care billing.
• Articulate what is necessary when billing critical care.

Patrick C. Cullinan, DO, FACOI, Neurosurgical Intensivist Specialist, Department of Neurosurgery, University of Texas Health Science Center

Rubaiya Mallay, DO, FACOI, FACR (she/her/hers), Rheumatologist, Suncoast Internal Medicine Consultants

Learning Objectives:

• Define AI, NLP, Machine Learning.
• Understand the Current Landscape of Informatics.
• Be Familiar with Emerging AI Trends in Clinical Informatics.

Charlene A. LePane, DO, MBA, MSPH, FACOI, FACG, FASGE (she/her/hers), Chief Medical Information Officer/Gastroenterologist, AdventHealth

Learning Objectives:

• Learn about the history of low dose radiation therapy in musculoskeletal diseases.
• Learn the host of common indications for its use and Learn how to select appropriate patients who may benefit from LDRT.
• Understand how to counsel patient for risks of therapy and Understand the treatment course and when to retreat patients.

Adam J. Grunbaum, DO, FACOI, FACR, FACP, Program Director, USF Morsani HCA Healthcare Consortium - Trinity Medical Center

Rubaiya Mallay, DO, FACOI, FACR (she/her/hers), Rheumatologist, Suncoast Internal Medicine Consultants

More details coming soon

Learning Objectives:

• Identifying some of the limitations of a rheumatoid factor in diagnosing rheumatoid arthritis and understanding some of the additional antibodies available.
• To become more familiar with molecular signature testing Understanding a novel new treatment for rheumatoid arthritis.
• Recognize newer biologic therapeutics used in rheumatology outside of rheumatoid arthritis.

Megan Eshbaugh, DO, FACOI, FACR (she/her/hers), Rheumatologist, Center for Arthritis and Rheumatic Diseases

Rubaiya Mallay, DO, FACOI, FACR (she/her/hers), Rheumatologist, Suncoast Internal Medicine Consultants

Learning Objectives:

• Describe the advantages of using high-flow oxygen when compared to low-flow oxygen.
• Identify individuals MOST appropriate for noninvasive positive pressure ventilation.
• Explain the differences between Average Volume Assisted Pressure Support (AVAPS) and Bilevel Positive Pressure Ventilation.

Patrick C. Cullinan, DO, FACOI, Neurosurgical Intensivist Specialist, Department of Neurosurgery, University of Texas Health Science Center

David H. Lindner, DO, MBA, FCCP, FACOI (he/him/his), Section Chair, Pulmonary & Critical Care, NCH Health Care